Published in J Ethnopharmacol on September 10, 2006
Dietary agents for chemoprevention of prostate cancer. Cancer Lett (2008) 1.72
Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach. Curr Drug Targets (2011) 1.53
The effect of pomegranate fresh juice versus pomegranate seed powder on metabolic indices, lipid profile, inflammatory biomarkers, and the histopathology of pancreatic islets of Langerhans in streptozotocin-nicotinamide induced type 2 diabetic Sprague-Dawley rats. BMC Complement Altern Med (2017) 1.39
Antibacterial and antifungal activities of punica granatum peel extracts against oral pathogens. J Dent (Tehran) (2011) 1.26
Total phenolic distribution of juice, peel, and seed extracts of four pomegranate cultivars. Pharmacogn Mag (2011) 1.17
Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro. J Inflamm (Lond) (2008) 1.14
Antibacterial, antioxidant and tyrosinase-inhibition activities of pomegranate fruit peel methanolic extract. BMC Complement Altern Med (2012) 1.05
Nutraceuticals and prostate cancer prevention: a current review. Nat Rev Urol (2009) 1.00
In Vitro and In Vivo Antibacterial Activity of Punica granatum Peel Ethanol Extract against Salmonella. Evid Based Complement Alternat Med (2011) 0.99
Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis (2011) 0.97
The efficacy of Punica granatum extract in the management of recurrent aphthous stomatitis. J Res Pharm Pract (2013) 0.96
A Review on Antihyperglycemic and Antihepatoprotective Activity of Eco-Friendly Punica granatum Peel Waste. Evid Based Complement Alternat Med (2013) 0.95
Protective effect of pomegranate-derived products on UVB-mediated damage in human reconstituted skin. Exp Dermatol (2009) 0.95
A review on the anti-inflammatory activity of pomegranate in the gastrointestinal tract. Evid Based Complement Alternat Med (2013) 0.94
Nutritional protective mechanisms against gut inflammation. J Nutr Biochem (2013) 0.92
Antidiabetic and antihyperlipidemic effects of ethanolic extract of leaves of Punica granatum in alloxan-induced non-insulin-dependent diabetes mellitus albino rats. Indian J Pharmacol (2012) 0.91
Greco-arab and islamic herbal-derived anticancer modalities: from tradition to molecular mechanisms. Evid Based Complement Alternat Med (2011) 0.90
Role of dietary polyphenols in the management of peptic ulcer. World J Gastroenterol (2015) 0.90
Pomegranate fruit as a rich source of biologically active compounds. Biomed Res Int (2014) 0.89
Pomegranate seed oil reduces intestinal damage in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2012) 0.88
Phenolics of pomegranate peels: extraction optimization by central composite design and alpha glucosidase inhibition potentials. J Food Sci Technol (2013) 0.88
Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents. Evid Based Complement Alternat Med (2013) 0.88
Effects of phenolic compounds of fermented thai indigenous plants on oxidative stress in streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med (2011) 0.87
Curcuma longa extract associated with white pepper lessens high fat diet-induced inflammation in subcutaneous adipose tissue. PLoS One (2013) 0.87
Pharmacological investigations of Punica granatum in glycerol-induced acute renal failure in rats. Indian J Pharmacol (2011) 0.87
Tissue culture-mediated biotechnological intervention in pomegranate: a review. Plant Cell Rep (2010) 0.87
Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway. Evid Based Complement Alternat Med (2013) 0.87
Ellagitannins in Cancer Chemoprevention and Therapy. Toxins (Basel) (2016) 0.86
Punicalagin Induces Nrf2/HO-1 Expression via Upregulation of PI3K/AKT Pathway and Inhibits LPS-Induced Oxidative Stress in RAW264.7 Macrophages. Mediators Inflamm (2015) 0.85
Studies on the Cytotoxic Activities of Punica granatum L. var. spinosa (Apple Punice) Extract on Prostate Cell Line by Induction of Apoptosis. ISRN Pharm (2012) 0.84
Pomegranate and its derivatives can improve bone health through decreased inflammation and oxidative stress in an animal model of postmenopausal osteoporosis. Eur J Nutr (2014) 0.83
Antioxidant and antibacterial potential of pomegranate peel extracts. J Food Sci Technol (2013) 0.83
Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy. Oxid Med Cell Longev (2015) 0.83
Acute and long term effects of grape and pomegranate juice consumption on endothelial dysfunction in pediatric metabolic syndrome. J Res Med Sci (2011) 0.82
Effect of pomegranate seed oil against gentamicin -induced nephrotoxicity in rat. J Food Sci Technol (2012) 0.82
Antifungal activity of the ethanolic extracts of Punica granatum L. and evaluation of the morphological and structural modifications of its compounds upon the cells of Candida spp. Braz J Microbiol (2013) 0.82
Isolation of Antidiabetic Principle from Fruit Rinds of Punica granatum. Evid Based Complement Alternat Med (2012) 0.82
Efficacy and safety of pomegranate medicinal products for cancer. Evid Based Complement Alternat Med (2015) 0.81
Recent progress of research on medicinal mushrooms, foods, and other herbal products used in traditional Chinese medicine. J Tradit Complement Med (2012) 0.81
Korean Red Ginseng Suppresses Metastasis of Human Hepatoma SK-Hep1 Cells by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase Plasminogen Activator. Evid Based Complement Alternat Med (2012) 0.81
SPAR profiles and genetic diversity amongst pomegranate (Punica granatum L.) genotypes. Physiol Mol Biol Plants (2009) 0.81
Antibacterial activity of fresh pomegranate juice against clinical strains of Staphylococcus epidermidis. Food Nutr Res (2015) 0.81
Pomegranate and its components as alternative treatment for prostate cancer. Int J Mol Sci (2014) 0.81
Ethnopharmacological Survey of Plants Used in the Traditional Treatment of Gastrointestinal Pain, Inflammation and Diarrhea in Africa: Future Perspectives for Integration into Modern Medicine. Animals (Basel) (2013) 0.80
Protective effect of pomegranate flower extract against gentamicin-induced renal toxicity in male rats. J Renal Inj Prev (2015) 0.79
Mixed pro- and anti-oxidative effects of pomegranate polyphenols in cultured cells. Int J Mol Sci (2014) 0.79
Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum. BMC Complement Altern Med (2017) 0.79
Establishment of pomegranate (Punica granatum) hairy root cultures for genetic interrogation of the hydrolyzable tannin biosynthetic pathway. Planta (2012) 0.79
Impact of ellagic acid in bone formation after tooth extraction: an experimental study on diabetic rats. ScientificWorldJournal (2014) 0.79
Growth-Inhibitory and Apoptosis-Inducing Effects of Punica granatum L. var. spinosa (Apple Punice) on Fibrosarcoma Cell Lines. Adv Pharm Bull (2014) 0.78
Evaluation of antioxidant and antiradical properties of Pomegranate (Punica granatum L.) seed and defatted seed extracts. J Food Sci Technol (2013) 0.78
Plants with potential use on obesity and its complications. EXCLI J (2015) 0.78
Preventive Effect of Three Pomegranate (Punica granatum L.) Seeds Fractions on Cerulein-Induced Acute Pancreatitis in Mice. Int J Prev Med (2014) 0.78
Ellagic Acid and Resveratrol Prevent the Development of Cisplatin Resistance in the Epithelial Ovarian Cancer Cell Line A2780. J Cancer (2016) 0.77
Antiangiogenic and antiproliferative effects of black pomegranate peel extract on melanoma cell line. Res Pharm Sci (2015) 0.77
Antispasmodic Effects of Aqueous and Hydroalcoholic Punica granatum Flower Extracts on the Uterus of Non-pregnant Rats. J Reprod Infertil (2012) 0.77
Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis. Nutr Cancer (2015) 0.77
Lipid Lowering Effect of Punica granatum L. Peel in High Lipid Diet Fed Male Rats. Evid Based Complement Alternat Med (2014) 0.77
The potential role of Punica granatum treatment on murine malaria-induced hepatic injury and oxidative stress. Parasitol Res (2015) 0.77
Iminoflavones combat 1,2-dimethyl hydrazine-induced aberrant crypt foci development in colon cancer. Biomed Res Int (2014) 0.77
Aldose reductase inhibitory activity and antioxidant capacity of pomegranate extracts. Interdiscip Toxicol (2012) 0.77
Therapeutic potential of biodegradable microparticles containing Punica granatum L. (pomegranate) in murine model of asthma. Inflamm Res (2013) 0.76
Inhibitory effect of a standardized pomegranate fruit extract on Wnt signalling in 1, 2-dimethylhydrazine induced rat colon carcinogenesis. Dig Dis Sci (2013) 0.76
Effect of frozen storage on the anthocyanins and phenolic components of pomegranate juice. J Food Sci Technol (2011) 0.75
Multiple Activities of Punica granatum Linne against Acne Vulgaris. Int J Mol Sci (2017) 0.75
The effect of pomegranate mouthrinse on Streptococcus mutans count and salivary pH: An in vivo study. J Adv Pharm Technol Res (2016) 0.75
Stability of total phenolic concentration and antioxidant capacity of extracts from pomegranate co-products subjected to in vitro digestion. BMC Complement Altern Med (2016) 0.75
Evaluation of anti-epileptic activity of leaf extracts of Punica granatum on experimental models of epilepsy in mice. J Intercult Ethnopharmacol (2016) 0.75
Growth inhibitory effects of crude pomegranate peel extract on chronic myeloid leukemia, K562 cells. Int J Appl Basic Med Res (2015) 0.75
Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients. Eur J Clin Nutr (2016) 0.75
Anti-climacterium effects of pomegranate concentrated solutions in ovariectomized ddY mice. Exp Ther Med (2017) 0.75
Protective effects of carvacrol and pomegranate against methotrexate-induced intestinal damage in rats. Int J Clin Exp Med (2015) 0.75
Evidence of Some Natural Products with Antigenotoxic Effects. Part 1: Fruits and Polysaccharides. Nutrients (2017) 0.75
Pomegranate Intake Protects Against Genomic Instability Induced by Medical X-rays In Vivo in Mice. Nutr Cancer (2016) 0.75
Development of a nested-PCR assay for the rapid detection of Pilidiella granati in pomegranate fruit. Sci Rep (2017) 0.75
Benefits of pomegranate (Punica granatum Linn) fruit extracts to weight changes, total protein, and uric acid in white rats (Rattus norvegicus) as an animal model of acute renal failure. Vet World (2016) 0.75
The effects of pomegranate extract on normal adult rat kidney: A stereological study. Vet Res Forum (2016) 0.75
Estimating fermentation characteristics and nutritive value of ensiled and dried pomegranate seeds for ruminants using in vitro gas production technique. Open Vet J (2012) 0.75
Topical microemulsion containing Punica granatum extract: its control over skin erythema and melanin in healthy Asian subjects. Postepy Dermatol Alergol (2014) 0.75
Cigarette Smoking-Induced Cardiac Hypertrophy, Vascular Inflammation and Injury Are Attenuated by Antioxidant Supplementation in an Animal Model. Front Pharmacol (2016) 0.75
Antihyperlipidemic effects of Citrus sinensis, Citrus paradisi, and their combinations. J Pharm Bioallied Sci (2016) 0.75
The Effects of Punica granatum Flower Extract on Skin Injuries Induced by Burn in Rats. Adv Pharmacol Sci (2017) 0.75
Pomegranate Peel Extract Prevents Bone Loss in a Preclinical Model of Osteoporosis and Stimulates Osteoblastic Differentiation in Vitro. Nutrients (2015) 0.75
Protective effect of pomegranate seed oil against H2O2 -induced oxidative stress in cardiomyocytes. Avicenna J Phytomed (2017) 0.75
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM). Nutrients (2016) 0.75
A simple method for calculation of basic molecular properties of nutrients and their use as a criterion for a healthy diet. F1000Res (2017) 0.75
Pomegranate for Prevention and Treatment of Cancer: An Update. Molecules (2017) 0.75
Antimetastatic activity and low systemic toxicity of tetradecyl gallate in a preclinical melanoma mouse model. Invest New Drugs (2011) 0.75
Bioavailability of curcumin: problems and promises. Mol Pharm (2007) 8.72
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18
Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res (2008) 4.29
Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res (2005) 2.46
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc Natl Acad Sci U S A (2006) 2.41
Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res (Phila) (2009) 2.06
PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway. Invest New Drugs (2014) 2.04
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Cancer Prev Res (Phila) (2008) 1.71
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors. Proc Natl Acad Sci U S A (2009) 1.65
Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res (2008) 1.63
Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Clin Cancer Res (2005) 1.55
Eicosanoid metabolism in squamous cell carcinoma cell lines derived from primary and metastatic head and neck cancer and its modulation by celecoxib. Cancer Biol Ther (2004) 1.49
Zyflamend-mediated inhibition of human prostate cancer PC3 cell proliferation: effects on 12-LOX and Rb protein phosphorylation. Cancer Biol Ther (2007) 1.47
Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer (2009) 1.42
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer (2008) 1.36
Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids. Prostaglandins Leukot Essent Fatty Acids (2006) 1.33
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res (2005) 1.32
The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res (2005) 1.22
Quantitative high-performance liquid chromatography/electrospray ionization tandem mass spectrometric analysis of 2- and 3-series prostaglandins in cultured tumor cells. Anal Biochem (2002) 1.21
Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach. Bone (2011) 1.21
Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants. J Biol Chem (2003) 1.18
A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer. Clin Cancer Res (2006) 1.18
Ficus spp. (fig): ethnobotany and potential as anticancer and anti-inflammatory agents. J Ethnopharmacol (2008) 1.16
Biological activity of celecoxib in the bronchial epithelium of current and former smokers. Cancer Prev Res (Phila) (2010) 1.15
Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem (2002) 1.15
Regulation of prostaglandin transporters in colorectal neoplasia. Cancer Prev Res (Phila) (2008) 1.15
Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. Cancer Prev Res (Phila) (2010) 1.12
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer. Clin Cancer Res (2003) 1.12
Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells. J Lipid Res (2004) 1.11
Quantifying synergism/antagonism using nonlinear mixed-effects modeling: a simulation study. Stat Med (2008) 1.10
Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na,K-ATPase alpha subunits as drug targets. Mol Cancer Ther (2009) 1.09
Silk-fibroin-coated liposomes for long-term and targeted drug delivery. Int J Nanomedicine (2006) 1.07
Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice. Hum Mol Genet (2002) 1.07
Opposing effects of n-6 and n-3 polyunsaturated fatty acids on pancreatic cancer growth. Pancreas (2008) 1.06
Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies. Clin Cancer Res (2009) 1.04
Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res (2004) 1.01
Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors. Carcinogenesis (2006) 1.00
Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer. J Clin Oncol (2002) 1.00
In vitro and in vivo neuroprotective activity of the cardiac glycoside oleandrin from Nerium oleander in brain slice-based stroke models. J Neurochem (2011) 0.99
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products. Cancer Res (2005) 0.98
Silk fibroin mediated delivery of liposomal emodin to breast cancer cells. Int J Pharm (2007) 0.98
Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev (2007) 0.98
Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells. Cancer Res (2005) 0.97
Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells. Oncogene (2005) 0.97
Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model. Carcinogenesis (2002) 0.96
Inhibition of proliferation of PC3 cells by the branched-chain fatty acid, 12-methyltetradecanoic acid, is associated with inhibition of 5-lipoxygenase. Prostate (2003) 0.96
Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis (2009) 0.94
An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesis. Oncogene (2005) 0.92
Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia. Neoplasia (2005) 0.91
Eupalmerin acetate, a novel anticancer agent from Caribbean gorgonian octocorals, induces apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway. Mol Cancer Ther (2007) 0.91
Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors. Biochem J (2002) 0.91
Nerium oleander derived cardiac glycoside oleandrin is a novel inhibitor of HIV infectivity. Fitoterapia (2012) 0.90
Docetaxel secretion in tears: association with lacrimal drainage obstruction. Arch Ophthalmol (2002) 0.89
Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites. PLoS One (2011) 0.89
BDNF mediates neuroprotection against oxygen-glucose deprivation by the cardiac glycoside oleandrin. J Neurosci (2014) 0.88
Pharmacokinetics of caffeic acid phenethyl ester and its catechol-ring fluorinated derivative following intravenous administration to rats. Biopharm Drug Dispos (2009) 0.88
In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations. Int J Radiat Oncol Biol Phys (2002) 0.88
Rodent Plasmodium: population dynamics of early sporogony within Anopheles stephensi mosquitoes. J Parasitol (2008) 0.88
2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization. J Vasc Interv Radiol (2004) 0.87
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid. Cancer Prev Res (Phila) (2008) 0.87
Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer. Clin Cancer Res (2007) 0.87
Zyflamend, a polyherbal preparation, inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of NF-kappa B activation and NF-kappa B-regulated gene products. Nutr Cancer (2007) 0.87
Gamma tocopherol upregulates the expression of 15-S-HETE and induces growth arrest through a PPAR gamma-dependent mechanism in PC-3 human prostate cancer cells. Nutr Cancer (2009) 0.87
Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation. Mol Carcinog (2013) 0.85
Punica granatum: heuristic treatment for diabetes mellitus. J Med Food (2007) 0.85
Determinants of human and mouse melanoma cell sensitivities to oleandrin. J Exp Ther Oncol (2008) 0.85
Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines. J Exp Ther Oncol (2007) 0.84
Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats. Cancer Chemother Pharmacol (2002) 0.83
Zyflamend reduces LTB4 formation and prevents oral carcinogenesis in a 7,12-dimethylbenz[alpha]anthracene (DMBA)-induced hamster cheek pouch model. Carcinogenesis (2008) 0.83
Cellular location and expression of Na+, K+ -ATPase α subunits affect the anti-proliferative activity of oleandrin. Mol Carcinog (2012) 0.83
Phase I and pharmacological study of oral 9-aminocamptothecin colloidal dispersion (NSC 603071) in patients with advanced solid tumors. Clin Cancer Res (2003) 0.82
γ-Tocotrienol induces growth arrest through a novel pathway with TGFβ2 in prostate cancer. Free Radic Biol Med (2011) 0.82
Arachidonic acid metabolism in human prostate cancer. Int J Oncol (2012) 0.82
Pomegranate (Punica granatum) seed linolenic acid isomers: concentration-dependent modulation of estrogen receptor activity. Endocr Res (2010) 0.82
Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integr Cancer Ther (2009) 0.82
Human tumor cell sensitivity to oleandrin is dependent on relative expression of Na+, K+ -ATPase subunitst. J Exp Ther Oncol (2010) 0.81
Metabolism of homoharringtonine, a cytotoxic component of the evergreen plant Cephalotaxus harringtonia. J Exp Ther Oncol (2003) 0.81
Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst (2009) 0.79
Survival impact of integrative cancer care in advanced metastatic breast cancer. Breast J (2009) 0.79
Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate. J Exp Ther Oncol (2004) 0.79
A classification model to predict synergism/antagonism of cytotoxic mixtures using protein-drug docking scores. BMC Pharmacol (2008) 0.79
Evaluation of targeted arterial delivery of the branched chain fatty acid 12-methyltetradecanoic acid as a novel therapy for solid tumors. J Exp Ther Oncol (2005) 0.78
Structure-activity models of oral clearance, cytotoxicity, and LD50: a screen for promising anticancer compounds. BMC Pharmacol (2008) 0.78
The resistance to the tumor suppressive effects of COX inhibitors and COX-2 gene disruption in TRAMP mice is associated with the loss of COX expression in prostate tissue. Carcinogenesis (2007) 0.78
Murine pharmacokinetics and metabolism of oleandrin, a cytotoxic component of Nerium oleander. J Exp Ther Oncol (2002) 0.77
Use of microdialysis to study platinum anticancer agent pharmacokinetics in preclinical models. J Exp Ther Oncol (2002) 0.77
Zyflamend mediates therapeutic induction of autophagy to apoptosis in melanoma cells. Nutr Cancer (2011) 0.77
Perioperative polyphenon E, a green tea extract, does not affect the wound complication rate in mice after sham laparotomy yet has an inhibitory effect on wound healing. Surg Innov (2012) 0.76
Response to 'Probable hepatotoxicity related to Nerium oleander extract in a patient with metastatic synovial sarcoma of the knee'. J Altern Complement Med (2009) 0.76
Quantitative determination of fluorinated caffeic acid phenethyl ester derivative from rat blood plasma by liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.75
Final results of a phase I and pharmacokinetic study of gamma-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors. Cancer Chemother Pharmacol (2003) 0.75
Evaluation of in vitro drug interactions with karenitecin, a novel, highly lipophilic camptothecin derivative in phase II clinical development. J Clin Pharmacol (2003) 0.75
Simultaneous reduction of particulate matter and NO(x) emissions using 4-way catalyzed filtration systems. Environ Sci Technol (2013) 0.75
Effects of host species and life stage on the helminth communities of sympatric northern leopard frogs (Lithobates pipiens) and wood frogs (Lithobates sylvaticus) in the Sheyenne National Grasslands, North Dakota. J Parasitol (2013) 0.75